Domov › Rak prostate › Minnesota › Minneapolis
Klinične študije za Rak prostate v Minneapolis, MN
23 študij za Rak prostate išče udeležence na lokacijah v Minneapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi stran
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Vključevanje udeležencevFaza 2
- Hennepin County Medical Center, Minneapolis
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- University Of Minnesota, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Vključevanje udeležencevFaza 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Vključevanje udeležencevFaza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · 5 mi stran
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Vključevanje udeležencevFaza 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Vključevanje udeležencevFaza 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Vključevanje udeležencevFaza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · 5 mi stran
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Vključevanje udeležencevFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Minneapolis VA Medical Center, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1/2
- Research Site, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Vključevanje udeležencevFaza 2
- Masonic Cancer Center, Minneapolis
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Vključevanje udeležencevFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- in še 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Vključevanje udeležencevFaza 1
- University of Minnesota Medical Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 1
- Minnesota Oncology Hematology, Minneapolis
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Vključevanje udeležencevFaza 1
- University of Minnesota, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
Vključevanje udeležencevFaza 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mi stran
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Vključevanje udeležencevFaza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- in še 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Allina Health Cancer Institute, Minneapolis
Vitamin D for Prostate Endocrine Therapy
Vključevanje udeležencevFaza 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Vključevanje udeležencevFaza 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Študije za Rak prostate v drugih mestih
- New York City, NY103 študij
- Houston, TX76 študij
- Los Angeles, CA61 študij
- Boston, MA59 študij
- St. Louis, MO46 študij
- Chicago, IL45 študij
- San Francisco, CA45 študij
- Philadelphia, PA44 študij
- Baltimore, MD43 študij
- Nashville, TN42 študij
- Seattle, WA42 študij
- Washington, DC38 študij
Druge študije v Minneapolis
- Rak dojke27 študij
- Nemalicelični pljučni rak26 študij
- Rak jajčnikov24 študij
- Rak (vse vrste)22 študij
- Srčno popuščanje21 študij
- Rak pljuč20 študij
- Akutna mieločna levkemija20 študij
- Kolorektalni rak19 študij
- Rak endometrija18 študij
- Parkinsonova bolezen17 študij
- Srčno-žilne bolezni15 študij
- Bolezen venčnih arterij13 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.